Skip to main content

Peer Review reports

From: tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma

Original Submission
2 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Feb 2021 Reviewed Reviewer Report
13 Feb 2021 Reviewed Reviewer Report
26 Feb 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 4
26 Feb 2021 Submitted Manuscript version 4
27 Feb 2021 Reviewed Reviewer Report
3 Mar 2021 Reviewed Reviewer Report
13 Mar 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 5
13 Mar 2021 Submitted Manuscript version 5
17 Mar 2021 Reviewed Reviewer Report
20 Mar 2021 Reviewed Reviewer Report
22 Mar 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 6
22 Mar 2021 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
2 Apr 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 8
2 Apr 2021 Submitted Manuscript version 8
9 Apr 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 9
9 Apr 2021 Submitted Manuscript version 9
11 Apr 2021 Reviewed Reviewer Report
12 Apr 2021 Reviewed Reviewer Report
24 Apr 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 10
24 Apr 2021 Submitted Manuscript version 10
27 Apr 2021 Author responded Author comments - Yunfeng Fu
Resubmission - Version 11
27 Apr 2021 Submitted Manuscript version 11
28 Apr 2021 Reviewed Reviewer Report
29 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 12
Submitted Manuscript version 12
Publishing
4 May 2021 Editorially accepted
11 May 2021 Article published 10.1186/s12859-021-04167-8

You can find further information about peer review here.

Back to article page